164 related articles for article (PubMed ID: 12027790)
1. Estrogen and progesterone receptors in non small cell lung cancer patients.
Radzikowska E; Langfort R; Giedronowicz D
Ann Thorac Cardiovasc Surg; 2002 Apr; 8(2):69-73. PubMed ID: 12027790
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen and progesterone receptors in non-small-cell lung cancer: immunohistochemical study.
Su JM; Hsu HK; Chang H; Lin SL; Chang HC; Huang MS; Tseng HH
Anticancer Res; 1996; 16(6B):3803-6. PubMed ID: 9042261
[TBL] [Abstract][Full Text] [Related]
3. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
Vargas SO; Leslie KO; Vacek PM; Socinski MA; Weaver DL
Cancer; 1998 Apr; 82(8):1495-500. PubMed ID: 9554526
[TBL] [Abstract][Full Text] [Related]
4. Highly concordant coexpression of aromatase and estrogen receptor beta in non-small cell lung cancer.
Abe K; Miki Y; Ono K; Mori M; Kakinuma H; Kou Y; Kudo N; Koguchi M; Niikawa H; Suzuki S; Evans DB; Sugawara S; Suzuki T; Sasano H
Hum Pathol; 2010 Feb; 41(2):190-8. PubMed ID: 19800101
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor in non-small cell lung cancer--a potent prognostic factor and possible target for endocrine therapy.
Ishibashi H; Suzuki T; Suzuki S; Niikawa H; Lu L; Miki Y; Moriya T; Hayashi S; Handa M; Kondo T; Sasano H
Cancer Res; 2005 Jul; 65(14):6450-8. PubMed ID: 16024650
[TBL] [Abstract][Full Text] [Related]
6. The significance of estrogen receptor beta in 301 surgically treated non-small cell lung cancers.
Wu CT; Chang YL; Shih JY; Lee YC
J Thorac Cardiovasc Surg; 2005 Oct; 130(4):979-86. PubMed ID: 16214508
[TBL] [Abstract][Full Text] [Related]
7. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen receptor beta over expression in males with non-small cell lung cancer is associated with better survival.
Skov BG; Fischer BM; Pappot H
Lung Cancer; 2008 Jan; 59(1):88-94. PubMed ID: 17905466
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
11. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
[TBL] [Abstract][Full Text] [Related]
12. Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.
Fukuoka J; Fujii T; Shih JH; Dracheva T; Meerzaman D; Player A; Hong K; Settnek S; Gupta A; Buetow K; Hewitt S; Travis WD; Jen J
Clin Cancer Res; 2004 Jul; 10(13):4314-24. PubMed ID: 15240517
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and progesterone receptors in bronchogenic carcinoma.
Cagle PT; Mody DR; Schwartz MR
Cancer Res; 1990 Oct; 50(20):6632-5. PubMed ID: 2208126
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections.
Atkins D; Reiffen KA; Tegtmeier CL; Winther H; Bonato MS; Störkel S
J Histochem Cytochem; 2004 Jul; 52(7):893-901. PubMed ID: 15208356
[TBL] [Abstract][Full Text] [Related]
15. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer.
Ishikawa S; Nakagawa T; Miyahara R; Kawano Y; Takenaka K; Yanagihara K; Otake Y; Katakura H; Wada H; Tanaka F
Clin Cancer Res; 2005 Feb; 11(3):1198-202. PubMed ID: 15709189
[TBL] [Abstract][Full Text] [Related]
16. Selective expression of S100A7 in lung squamous cell carcinomas and large cell carcinomas but not in adenocarcinomas and small cell carcinomas.
Zhang H; Zhao Q; Chen Y; Wang Y; Gao S; Mao Y; Li M; Peng A; He D; Xiao X
Thorax; 2008 Apr; 63(4):352-9. PubMed ID: 18364444
[TBL] [Abstract][Full Text] [Related]
17. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
18. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
19. Sex-specific survival advantage with parathyroid hormone-related protein in non-small cell lung carcinoma patients.
Hastings RH; Laux AM; Casillas A; Xu R; Lukas Z; Ernstrom K; Deftos LJ
Clin Cancer Res; 2006 Jan; 12(2):499-506. PubMed ID: 16428492
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
